Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

Teddy Rosenbluth
Author: Teddy Rosenbluth

Written by

Teddy Rosenbluth

in

Appointments and Executive Changes, Cassava Sciences Inc, City College of New York, Clinical Trials, Drugs (Pharmaceuticals), Falsification of Data, Research, Securities and Commodities Violations
←Biden’s Student Loan Repayment Plan Blocked by Federal Appeals Court
Imagery Of A Bloodied Trump And Calls To ‘Fight’ Are Everywhere At The RNC→

More posts

  • YouTube Takes Most Of Japanese On-Demand Viewing – AMPD Analytics

  • North v South – the battle for global supremacy is tighter than ever

  • I’m Sorry, But I Just Don’t Think You’ll Be Able To Solve These Movie Chains On The First Try

  • How Donny Hathaway turned this soft rock cover into America’s defining song

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube